SCHEMBL25328702

SCHEMBL25328702

COc1cc(C=Cc2ccc(O)c(OC)c2)cc(OC)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 1.00
NFE2L2 Q16236 2/20 0.78
NQO2 P16083 3/20 0.76
NQO1 P15559 1/20 0.76
TTR P02766 3/20 0.75
ABL1 P00519 3/20 0.75
BCR P11274 3/20 0.75
ABCB1 P08183 2/20 0.75
BACE1 P56817 1/20 0.74
APP P05067 3/20 0.72
CYP1A1 P04798 3/20 0.72
CYP1B1 Q16678 3/20 0.72
ABCG2 Q9UNQ0 1/20 0.72
MYC P01106 1/20 0.72
TYR P14679 1/20 0.67
MAPT P10636 2/20 0.66
KDM4E B2RXH2 1/20 0.64
MEN1 O00255 1/20 0.64
NPC1 O15118 1/20 0.64
GAA P10253 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25328697 1.00 ALOX5 (1.00) ALOX5NFE2L2NQO2NQO1TTR
SCHEMBL17732299 0.89 TTR (0.85) ALOX5NFE2L2TTRABCB1BACE1
SCHEMBL30807100 0.89 TTR (0.85) ALOX5NFE2L2TTRABCB1BACE1
SCHEMBL671149 0.89 TTR (0.85) ALOX5NFE2L2TTRABCB1BACE1
SCHEMBL671150 0.89 TTR (0.85) ALOX5NFE2L2TTRABCB1BACE1
SCHEMBL614483 0.88 NFE2L2 (1.00) ALOX5NFE2L2NQO2TTRAPP
SCHEMBL614484 0.88 NFE2L2 (1.00) ALOX5NFE2L2NQO2TTRAPP
SCHEMBL3127862 0.87 ALOX5 (0.77) ALOX5NFE2L2NQO2TTRABL1
SCHEMBL3127856 0.87 ALOX5 (0.77) ALOX5NFE2L2NQO2TTRABL1
SCHEMBL2966533 0.86 ALOX5 (1.00) ALOX5NQO2NQO1TTRABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12466784-B2 Analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis APICAL MOLECULAR BIOTECH CO., LTD. (TW) 2025-11-11 US disclosed
EP-4136063-B1 NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS APICAL MOLECULAR BIOTECH CO LTD (TW) 2025-10-22 EP disclosed
US-20230234912-A1 NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS APICAL MOLECULAR BIOTECH CO., LTD. (TW) 2023-07-27 US disclosed
CN-115835860-A Novel analogues of pterostilbene amino acids with carbonate for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis 树顶分子生技股份有限公司 2023-03-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234912-A1 NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS FABP1, GLS2, SLC1A5 ALOX5 888/4885NFE2L2 2553/4885NQO2 4477/4885
US-12466784-B2 Analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis FABP1, GLS2, SLC1A5 ALOX5 904/4885NFE2L2 2476/4885NQO2 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.